115 related articles for article (PubMed ID: 7900742)
1. Diagnosis of microdeletion syndromes: high-resolution chromosome analysis versus fluorescence in situ hybridization.
Gopal VV; Roop H; Carpenter NJ
Am J Med Sci; 1995 Apr; 309(4):208-12. PubMed ID: 7900742
[TBL] [Abstract][Full Text] [Related]
2. Prader Willi/Angelman and DiGeorge/velocardiofacial syndrome deletions: diagnosis by primed in situ labeling (PRINS).
Tharapel AT; Kadandale JS; Martens PR; Wachtel SS; Wilroy RS
Am J Med Genet; 2002 Jan; 107(2):119-22. PubMed ID: 11807885
[TBL] [Abstract][Full Text] [Related]
3. Use of FISH technique in the diagnosis of chromosomal syndromes.
Iqbal MA; Ulmer C; Sakati N
East Mediterr Health J; 1999 Nov; 5(6):1218-24. PubMed ID: 11924115
[TBL] [Abstract][Full Text] [Related]
4. Implementation of Fluorescent in situ hybridization (FISH) as a method for detecting microdeletion syndromes - our first experiences.
Sukarova-Angelovska E; Piperkova K; Sredovska A; Ilieva G; Kocova M
Prilozi; 2007 Dec; 28(2):87-98. PubMed ID: 18356781
[TBL] [Abstract][Full Text] [Related]
5. Comparison of high resolution cytogenetics, fluorescence in situ hybridisation, and DNA studies to validate the diagnosis of Prader-Willi and Angelman's syndromes.
Smith A; Prasad M; Deng ZM; Robson L; Woodage T; Trent RJ
Arch Dis Child; 1995 May; 72(5):397-402. PubMed ID: 7618904
[TBL] [Abstract][Full Text] [Related]
6. Comparing two diagnostic laboratory tests for several microdeletions causing mental retardation syndromes: multiplex ligation-dependent amplification vs fluorescent in situ hybridization.
Cho EH; Park BY; Cho JH; Kang YS
Korean J Lab Med; 2009 Feb; 29(1):71-6. PubMed ID: 19262082
[TBL] [Abstract][Full Text] [Related]
7. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
[TBL] [Abstract][Full Text] [Related]
8. [Molecular diagnosis of Prader-Willi and Angelman syndromes: methylation, cytogenetics and FISH analysis].
Santa María L; Curotto B; Cortés F; Rojas C; Alliende MA
Rev Med Chil; 2001 Apr; 129(4):367-74. PubMed ID: 11413988
[TBL] [Abstract][Full Text] [Related]
9. FISH analysis in Prader-Willi and Angelman syndrome patients.
Bettio D; Rizzi N; Giardino D; Grugni G; Briscioli V; Selicorni A; Carnevale F; Larizza L
Am J Med Genet; 1995 Mar; 56(2):224-8. PubMed ID: 7625450
[TBL] [Abstract][Full Text] [Related]
10. Parental and chromosomal origins of microdeletion and duplication syndromes involving 7q11.23, 15q11-q13 and 22q11.
Thomas NS; Durkie M; Potts G; Sandford R; Van Zyl B; Youings S; Dennis NR; Jacobs PA
Eur J Hum Genet; 2006 Jul; 14(7):831-7. PubMed ID: 16617304
[TBL] [Abstract][Full Text] [Related]
11. Genetic testing for Prader-Willi and Angelman syndromes.
Schad CR; Jalal SM; Thibodeau SN
Mayo Clin Proc; 1995 Dec; 70(12):1195-6. PubMed ID: 7490922
[No Abstract] [Full Text] [Related]
12. [The use of molecular cytogenetic and cytogenetic techniques for the diagnosis of Prader-Willi and Angelman syndrome].
Iourov IY; Vorsanova SG; Kurinnaaya OS; Kolotii AD; Demidova IA; Kravets VS; Yurov YB
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(1):49-53. PubMed ID: 24637817
[TBL] [Abstract][Full Text] [Related]
13. Prenatal diagnosis of chromosome 15 abnormalities in the Prader-Willi/Angelman syndrome region by traditional and molecular cytogenetics.
Toth-Fejel S; Magenis RE; Leff S; Brown MG; Comegys B; Lawce H; Berry T; Kesner D; Webb MJ; Olson S
Am J Med Genet; 1995 Feb; 55(4):444-52. PubMed ID: 7762584
[TBL] [Abstract][Full Text] [Related]
14. High resolution chromosome analysis and fluorescence in situ hybridization in patients referred for Prader-Willi or Angelman syndrome.
Butler MG
Am J Med Genet; 1995 May; 56(4):420-2. PubMed ID: 7604853
[No Abstract] [Full Text] [Related]
15. Diagnostics of common microdeletion syndromes using fluorescence in situ hybridization: single center experience in a developing country.
Kurtovic-Kozaric A; Mehinovic L; Stomornjak-Vukadin M; Kurtovic-Basic I; Catibusic F; Kozaric M; Mesihovic-Dinarevic S; Hasanhodzic M; Glamuzina D
Bosn J Basic Med Sci; 2016 Mar; 16(2):121-5. PubMed ID: 26937776
[TBL] [Abstract][Full Text] [Related]
16. Comparison of high resolution chromosome banding and fluorescence in situ hybridization (FISH) for the laboratory evaluation of Prader-Willi syndrome and Angelman syndrome.
Delach JA; Rosengren SS; Kaplan L; Greenstein RM; Cassidy SB; Benn PA
Am J Med Genet; 1994 Aug; 52(1):85-91. PubMed ID: 7977469
[TBL] [Abstract][Full Text] [Related]
17. Angelman syndrome assessed by neurological and molecular cytogenetic investigations.
Hou JW; Wang PJ; Wang TR
Pediatr Neurol; 1997 Jan; 16(1):17-22. PubMed ID: 9044396
[TBL] [Abstract][Full Text] [Related]
18. Prenatal diagnosis of Prader-Willi syndrome and Angelman syndrome for fetuses with suspicious deletion of chromosomal region 15q11-q13.
Chang CW; Hsu HK; Kao CC; Huang JY; Kuo PL
Int J Gynaecol Obstet; 2014 Apr; 125(1):18-21. PubMed ID: 24434231
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic testing: a cost analysis for Prader-Willi and Angelman syndromes.
Monaghan KG; Van Dyke DL; Feldman G; Wiktor A; Weiss L
Am J Hum Genet; 1997 Jan; 60(1):244-7. PubMed ID: 8981972
[No Abstract] [Full Text] [Related]
20. Application of Interphase Fluorescent in Situ Hybridization: a Screening Tool for the Diagnosis of Microdeletion Syndrome.
Im KO; Kim SO; Lee JS; Park SH; Kim SM; Park HS; Kim SW; Kim JA; Lee DS
Clin Lab; 2022 Apr; 68(4):. PubMed ID: 35443603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
